HAVCR2 and chordoma: A variety of immunosuppressive checkpoints such as PD-1/PD-L1, CD47/SIRPα, TIM3, and CTLA4 are expressed on the surface of both chordoma cells and immune cells, and ICIs are the most widely performed strategy in the field of chordoma immunotherapy.